Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |